Peer Review History

Original SubmissionJanuary 21, 2020
Decision Letter - Esteban Tlelo-Cuautle, Editor

PONE-D-20-00374

Forecasting the monthly incidence rate of brucellosis in west of Iran using time series and data mining from 2010 to 2019

PLOS ONE

Dear Dr Cheraghi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Reviewers' comments are listed to perform the required changes before acceptance of your work. 

We would appreciate receiving your revised manuscript by Apr 10 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Esteban Tlelo-Cuautle, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (if provided):

You are encouraged to attend reviewers' comments to improve the impact of your work.

Journal Requirements:

When submitting your revision, we need you to address these additional requirements:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf and http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Cover letter of your manuscript:

"This study was funded by the Vice-Chancellor of Research and Technology of Hamadan

University of Medical Sciences. The funders had no role in study design, data collection and analysis,

decision to publish, or preparation of the manuscript."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"None."

3. Thank you for stating the following in your Competing Interests section: 

"None declared."

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now

This information should be included in your cover letter; we will change the online submission form on your behalf.

4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

5. Please amend your authorship list in your manuscript file to include author Hadi Bagheri, Leili Tapak, Manoochehr Karami, Zahra Hasankhani, Hamidreza Najari, Safdar Karimi

6. Please amend your list of authors on the manuscript to ensure that each author is linked to an affiliation. Authors’ affiliations should reflect the institution where the work was done (if authors moved subsequently, you can also list the new affiliation stating “current affiliation:….” as necessary).

7. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 5 in your text; if accepted, production will need this reference to link the reader to the Table.

8. Please include a copy of Table 10 which you refer to in your text on page 7.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear Editor

Please find the comments below.

Bests,

Comments for the authors

The authors compared the performance of four machine learning methods in forecasting human brucellosis. Generally the subject is interesting and the manuscript is well written. In my concern, there are some minor issues with the manuscript as follows:

Are there other disease that could look like the case definition? How sensitive and specific to Brucellosis is that definition.

Do the patients have to have all of the signs at one time?

Do the authors mean random forest by “random accumulation”? Please correct them as random accumulation is not the usual term.

According to golden rules of reporting the numbers (BMJ publication) the numbers under 10, must be presented in letters!

The majority of the references (References: 5, 6, 20 and 22) are not up to date.

All formulas must be numbered.

Reviewer #2: Overall, I think this manuscript is well written. Just a few suggestions for the result section.

1. Table 1 and Table 2, add p values to compare the incidence between each characteristics.

2. Add a time series correlation matrix or plot to show the correlation between the characteristics in Table 4 and the time series of brucellosis.

3 Explain in detail how you optimize the parameters in your four machine learning models. For example, how did you choose the number of hidden layers for neural network. Please also list those parameters for the other models, and explain how did you determine these parameters.

4 In the discussion section, please include more discussion how to apply these models in real infectious disease surveillance.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Xingyu Zhang

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Dear Editor,

Thank you for your constructive and valuable comments. Below we have provided a point-by-point response to all the comments.

Comments to the Author

The authors compared the performance of four machine learning methods in forecasting human brucellosis. Generally, the subject is interesting and the manuscript is well written. In my concern, there are some minor issues with the manuscript as follows:

Are there other disease that could look like the case definition? How sensitive and specific to Brucellosis is that definition.

No, there aren't. The clinical – epidemiological symptoms of brucellosis were considered disease cases including : fever, myalgia and para-clinical symptoms are very non-specific and it may be like to several disease, but the definition of definitive case in our study was the positive results of two routine lab tests for brucellosis) including, Wright’s (diagnostic test for brucellosis; values greater than 1.8 indicate presence of infection) and 2ME (Mercaptoethanol Brucella agglutination test) (brucellosis confirmatory test, which if greater than or equal to 1.4 is indicative of the presence of infection. Please refer to Page 13th lines: 132-35

Do the patients have to have all of the signs at one time?

Not necessarily, because this is the prospective cohort studies, that may be people affect the brucellosis in various time points.

Do the authors mean random forest by “random accumulation”? Please correct them as random accumulation is not the usual term.

Thanks revised.

According to golden rules of reporting the numbers (BMJ publication) the numbers under 10, must be presented in letters!

Thanks revised.

The majority of the references (References: 5, 6, 20 and 22) are not up to date.

Thanks, revised.

All formulas must be numbered. Thanks, revised. Pages 5-6

Thanks revised.

Reviewer #2: Overall, I think this manuscript is well written. Just a few suggestions for the result section.

1. Table 1 and Table 2, add p values to compare the incidence between each characteristics.

Thanks, revised. Please see table 1 and 2

2. Add a time series correlation matrix or plot to show the correlation between the characteristics in Table 4 and the time series of brucellosis.

The table added. Page 22

3 Explain in detail how you optimize the parameters in your four machine learning models. For example, how did you choose the number of hidden layers for neural network. Please also list those parameters for the other models, and explain how did you determine these parameters.

Edited. Page 8th lines 198-210 as follow as:

To implement the models, variables in Table 1 as well as climatic variables of wind speed (m/s) and temperature (Centigrade) were used as predictors and the numbers of brucellosis cases observed was used as the output….

4 In the discussion section, please include more discussion how to apply these models in real infectious disease surveillance.

Thanks, revised, as follow as: Page 13th Lines: 372-75

Attachments
Attachment
Submitted filename: Responce to reviewers.doc
Decision Letter - Esteban Tlelo-Cuautle, Editor

Forecasting the monthly incidence rate of brucellosis in west of Iran using time series and data mining from 2010 to 2019

PONE-D-20-00374R1

Dear Dr. Cheraghi,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

Esteban Tlelo-Cuautle, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

The updated manuscript is fine to be accepted

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear Editor

There is no comments for this manuscript and the authors provided approperiate answers.

The decision is to accept.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Formally Accepted
Acceptance Letter - Esteban Tlelo-Cuautle, Editor

PONE-D-20-00374R1

Forecasting the monthly incidence rate of brucellosis in west of Iran using time series and data mining from 2010 to 2019

Dear Dr. Cheraghi:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Esteban Tlelo-Cuautle

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .